🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 17 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
08/09/2006 50,63 51,00 49,10 50,30 -0,40% 3,75% 3.950
07/09/2006 52,20 53,50 50,50 50,50 -4,54% 5,75% 6.040
06/09/2006 52,50 53,70 52,00 52,90 +1,73% 3,24% 11.770
05/09/2006 52,50 52,50 50,30 52,00 +0,00% 4,19% 4.870
01/09/2006 49,40 52,40 49,40 52,00 +4,63% 6,07% 13.380
31/08/2006 52,00 52,00 48,50 49,70 +1,43% 6,73% 7.460
30/08/2006 47,70 51,30 46,50 49,00 +2,73% 10,06% 17.370
29/08/2006 48,00 48,70 46,50 47,70 -0,62% 4,58% 3.630
28/08/2006 48,07 48,30 47,00 48,00 -0,02% 2,70% 2.790
25/08/2006 47,20 49,00 47,20 48,01 +1,93% 3,81% 3.760
24/08/2006 48,50 48,50 47,10 47,10 -2,28% 2,89% 2.100
23/08/2006 49,00 49,43 48,00 48,20 -2,63% 2,92% 4.560
22/08/2006 50,00 50,00 48,50 49,50 -1,00% 3,00% 2.120
21/08/2006 49,10 50,00 48,70 50,00 +2,67% 2,65% 4.670
18/08/2006 47,70 50,17 47,10 48,70 +2,10% 6,44% 4.170
17/08/2006 48,60 49,90 47,10 47,70 -1,04% 5,76% 2.340
16/08/2006 46,80 52,50 46,70 48,20 +4,56% 12,39% 2.540
15/08/2006 46,60 46,60 45,10 46,10 +0,00% 3,22% 5.000
14/08/2006 49,80 49,80 45,70 46,10 -4,36% 8,23% 5.250
11/08/2006 50,20 50,20 47,10 48,20 -1,63% 6,18% 1.750
10/08/2006 47,50 49,70 47,50 49,00 -0,61% 4,63% 3.970
09/08/2006 51,80 51,80 48,30 49,30 -4,46% 6,76% 6.700
08/08/2006 51,60 52,00 50,10 51,60 +2,99% 3,68% 2.490
07/08/2006 49,60 52,00 49,60 50,10 +0,00% 4,84% 1.510
04/08/2006 52,10 52,10 50,00 50,10 -1,96% 4,03% 2.710
03/08/2006 50,50 51,90 47,00 51,10 +3,86% 9,70% 6.560
02/08/2006 48,90 50,00 48,80 49,20 +2,93% 2,45% 1.780
01/08/2006 52,30 52,45 47,00 47,80 -11,15% 10,42% 16.740
31/07/2006 49,30 53,90 47,50 53,80 +8,25% 12,98% 16.090
28/07/2006 49,50 50,50 46,30 49,70 +1,64% 8,48% 4.710